NASDAQ:LGST Semper Paratus Acquisition (LGST) Stock Price, News & Analysis → $21,000 in profits in six weeks? (From InvestorPlace) (Ad) Free LGST Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.51▼$5.4050-Day Range$4.51▼$4.7852-Week Range$4.08▼$12.03Volume12,500 shsAverage Volume30,930 shsMarket Capitalization$71.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesOwnershipShort InterestSocial MediaStock AnalysisHeadlinesOwnershipShort InterestSocial Media Get Semper Paratus Acquisition alerts: Email Address Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. About Semper Paratus Acquisition Stock (NASDAQ:LGST)Semper Paratus Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire companies operating in the transportation, supply chain, and logistics industries. Semper Paratus Acquisition Corporation was incorporated in 2021 and is based in New York, New York. Semper Paratus Acquisition Corporation operates as a subsidiary of Ssvk Associates, Llc.Read More Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. LGST Stock News HeadlinesFebruary 14, 2024 | finance.yahoo.comTevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGNFebruary 14, 2024 | globenewswire.comTevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGNMay 8, 2024 | InvestorPlace (Ad)Elon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” February 1, 2024 | msn.comSPAC Semper Paratus shareholders okay merger with Tevogen BioFebruary 1, 2024 | finance.yahoo.comSemper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen BioJanuary 24, 2024 | finance.yahoo.comSemper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on NasdaqJanuary 10, 2024 | investing.comSemper Paratus Acquisition Corp (LGST)January 5, 2024 | finance.yahoo.comTevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business CombinationMay 8, 2024 | InvestorPlace (Ad)Elon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” December 5, 2023 | finance.yahoo.comWith a 56% stake, Semper Paratus Acquisition Corporation (NASDAQ:LGST) insiders have a lot riding on the companySeptember 29, 2023 | finance.yahoo.comSemper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing RequirementSeptember 14, 2023 | finance.yahoo.comSemper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio IncJune 30, 2023 | msn.comTevogen to go public via merger with SPAC Semper ParatusJune 29, 2023 | reuters.comBiotech firm Tevogen Bio enters $1.2 bln SPAC deal for US listingJune 27, 2023 | morningstar.comSemper Paratus Acquisition Corp Class AApril 17, 2023 | finance.yahoo.comSemper Paratus Acquisition Corporation (LGST)February 24, 2023 | benzinga.comSemper Paratus Acq Stock (NASDAQ:LGSTU), Trade IdeasJanuary 25, 2023 | wsj.comSemper Paratus Acquisition Corp. Cl AFebruary 18, 2022 | gurufocus.comSaba Capital Management, L.P. Buys FTAC Zeus Acquisition Corp, Semper Paratus Acquisition Corp, ...See More Headlines Receive LGST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semper Paratus Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:LGST CUSIPN/A CIK1860871 Webwww.semperparatusspac.com Phone646-807-8832FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$4.41 million Net MarginsN/A Pretax MarginN/A Return on Equity-21.83% Return on Assets3.10% Debt Debt-to-Equity RatioN/A Current Ratio0.22 Quick Ratio0.22 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.33 per share Price / Cash Flow13.74 Book Value($1.10) per share Price / Book-4.10Miscellaneous Outstanding Shares15,820,000Free Float6,864,000Market Cap$71.35 million OptionableNot Optionable Beta-0.08 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Surendra K. Ajjarapu (Age 53)CEO & Chairman Mr. Francis Knuettel II (Age 58)M.B.A., Chief Financial Officer Key CompetitorsElutiaNASDAQ:ELUTAtara BiotherapeuticsNASDAQ:ATRATurnstone BiologicsNASDAQ:TSBXInstil BioNASDAQ:TILPrecision BioSciencesNASDAQ:DTILView All CompetitorsInstitutional OwnershipQuarry LPBought 55,000 shares on 2/20/2024Ownership: 0.348%Kim LLCBought 50,000 shares on 2/9/2024Ownership: 0.316%View All Institutional Transactions This page (NASDAQ:LGST) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semper Paratus Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
